Australia markets closed

CureVac N.V. (CVAC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
14.09-0.53 (-3.63%)
At close: 04:00PM EDT
14.13 +0.04 (+0.28%)
Pre-market: 05:21AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.68B
Enterprise value 2.02B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)21.48
Price/book (mrq)3.77
Enterprise value/revenue 17.24
Enterprise value/EBITDA -7.10

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-79.11%
S&P500 52-week change 3-9.13%
52-week high 376.22
52-week low 312.90
50-day moving average 316.40
200-day moving average 328.29

Share statistics

Avg vol (3-month) 3634.2k
Avg vol (10-day) 3965.94k
Shares outstanding 5187.12M
Implied shares outstanding 6N/A
Float 887.59M
% held by insiders 152.57%
% held by institutions 124.10%
Shares short (30 May 2022) 45.58M
Short ratio (30 May 2022) 48.38
Short % of float (30 May 2022) 47.75%
Short % of shares outstanding (30 May 2022) 42.98%
Shares short (prior month 28 Apr 2022) 47.66M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin -266.86%
Operating margin (ttm)-822.89%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)-45.17%

Income statement

Revenue (ttm)117.33M
Revenue per share (ttm)0.63
Quarterly revenue growth (yoy)143.00%
Gross profit (ttm)-135.09M
EBITDA -953.85M
Net income avi to common (ttm)-313.11M
Diluted EPS (ttm)-1.75
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)658.2M
Total cash per share (mrq)3.52
Total debt (mrq)40.66M
Total debt/equity (mrq)6.03
Current ratio (mrq)3.32
Book value per share (mrq)3.61

Cash flow statement

Operating cash flow (ttm)-673.13M
Levered free cash flow (ttm)N/A